United States

Analyst Research Report Snapshot


Peel Hunt: Toumaz (Buy) - Sensium progressing to commercialisation




Peel Hunt


02 Apr 2014





Companies referenced:


Available for Immediate Download

Final results were in line with expectations. Progress since the fundraising in November is encouraging, particularly in healthcare, where TMZ has built a direct pipeline and international distributor base in around three months. Hospital interest in the SensiumVitals patch appears to be strong, based on its potential to increase patient safety and reduce treatment costs. The current share price is underpinned by the consumer electronics business, and we see strong upside to the shares as Sensium proves its potential as a high volume medical device. Alexandra.Jarvis@peelhunt.com

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.